tiprankstipranks

Athena Countouriotis Insider Profile

4 Followers
Athena Countouriotis, SVP and Chief Medical Officer at Halozyme, holds 13.64K shares in Halozyme (Ticker: HALO), holds ― shares in Cardiff Oncology (Ticker: CRDF), holds 26.87K shares in Turning Point Therapeutics (Ticker: TPTX).
tipranks
Athena Countouriotis

Athena Countouriotis
Halozyme (HALO)
SVP and Chief Medical Officer

Ranked #6,591 out of 78,624 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+48.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
75.97%
14.36%
9.67%
0.00%
0.00% Others
A breakdown of Athena Countouriotis's holdings

Insider Roles

Turning Point Therapeutics
(TPTX)
President & CEO, Director
Halozyme
(HALO)
SVP and Chief Medical Officer
Passage Bio
(PASG)
Director
Cardiff Oncology
(CRDF)
Director
+2 other positions
Roles that Athena Countouriotis holds in companies

Most Profitable Insider Trade

Stock:
Turning Point Therapeutics
(TPTX)
Rating:Informative Buy
Date:Apr 24, 2019 - Apr 24, 2020
Return:+83.20%
The most profitable trade made by Athena Countouriotis

Athena Countouriotis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Halozyme
Feb 06, 2017
SVP and Chief Medical Officer
Uninformative Buy
84.59K
$548.66K
Cardiff Oncology
Director
Adverum Biotechnologies
Jun 21, 2017
SVP, Chief Medical Officer
Uninformative Buy
Turning Point Therapeutics
May 26, 2020
President & CEO, Director
Informative Buy
249.96K
$2.90M
Iovance Biotherapeutics
Director
Passage Bio
Mar 25, 2020
Director
Informative Buy
149.70K
$369.31K
AMBI
Ambit
List of latest transactions for each holding click on a transaction to see Athena Countouriotis's performance on stock

Athena Countouriotis insider profile FAQ

What is the percentage of profitable transactions made by Athena Countouriotis?
The percentage of profitable transactions made by Athena Countouriotis is 80%.
    What is the average return per transaction made by Athena Countouriotis?
    The average return per transaction made by Athena Countouriotis is 48.10%.
      What stocks does Athena Countouriotis hold?
      Athena Countouriotis holds: HALO, CRDF, ADVM, TPTX, IOVA, PASG, AMBI stocks.
        What was Athena Countouriotis’s latest transaction?
        Athena Countouriotis latest transaction was an Uninformative Buy of $84.59K.
          What was Athena Countouriotis's most profitable transaction?
          Athena Countouriotis’s most profitable transaction was an Informative Buy of TPTX stock on April 24, 2019. The return on the trade was 83.20%.
            What is Athena Countouriotis's role in Halozyme?
            Athena Countouriotis's role in Halozyme is SVP and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.